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Previouscasesofcoronaryembolismasacauseofmyocardialinfarction(MI)inassociationwithprostheticmechanicalvalveshave
been reported, but the fact that the patient was not aware of the importance of maintaining anticoagulation therapy is relevant in
this case. A 16-year-old female was referred for primary coronary intervention due to subacute anterolateral ST elevation MI, after
she decided to discontinue warfarin therapy three weeks before. Coronary angiography showed distal occlusion of the left anterior
descending coronary artery with an image suggesting embolic material. Conventional echocardiography demonstrated akinesia
of anteroseptal, inferior, and posterior segments of the left ventricle, with severe systolic dysfunction, beyond the intraventricular
thrombus. The presence of mechanic aortic prosthesis and no anticoagulation therapy are highly suggestive of coronary embolism
as the cause of MI.This case report conﬁrms that patient education is vital in our struggle to prevent this complication in high-risk
patients.
1.Introduction
Prosthetic mechanical valves carry a signiﬁcant thromboe-
mbolic risk justifying the use of long-term conventional
anticoagulation therapy with warfarin [1–3]. The present re-
port describes a case of embolic subacute anterolateral ST
elevation myocardial infarction in a younger patient
with aortic mechanical valve prosthesis who decided to
discontinue warfarin without medical advice.
2.CaseReport
In October 2009, a 16-year-old female presented to the
emergency department with sudden onset of severe chest
pain, vomiting, and diaphoresis one day earlier. She had
a history of rheumatic aortic stenosis and had received a
23mm St. Jude mechanical aortic valve and mitral valve
repair four years earlier. Although she had received medical
advice regarding constant and imminent thromboembolic
risk, she nonetheless decided to abruptly discontinue war-
farin and started taking oral contraceptive pills three weeks
earlier. She was a smoker but had no other risk factors for
coronary artery disease.
At admission, the patient was tachypneic at 25beats/min
with regular rhythm at 107beats/min. Her blood pressure
was 154/92mmHg. Cardiac auscultation was unchanged
with normal prosthetic valve clicks and systolic ejection
murmur grade 3/6. No crackles were heard over lungs. Elec-
trocardiographyshowedleft-axisdeviationwithSTelevation
in leads I, aVL, and V5 to V6, compatible with anterolateral
wall subacute myocardial infarction (Figure 1). Laboratory
tests revealed cardiac troponin I >50ng/mL (upper limit
0.01ng/mL)andRNIof1.4.Transthoracicechocardiography
examination showed normally functioning aortic valve pros-
thesis with evidence of intraventricular thrombus (Figure 2)
and akinesia of the anteroseptal, inferior, and posterior
segments of the left ventricle.
Oxygen, acetylsalicylic acid, clopidogrel, and heparin
were administered, and the patient was transferred to the
catheterization laboratory. Coronary angiography showed
a distal occlusion of the left anterior descending coronary2 Case Reports in Medicine
Figure 1: Electrocardiography showing left-axis deviation with ST
elevation, T-wave inversion and Q-waves in leads I, aVL, and V5 to
V6, compatible with subacute anterolateral myocardial infarction
and a single ectopic beat.
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Figure 2: Transthoracic echocardiogram image showing thrombus
sessile (white arrow) on left ventricular apex (LV).
artery with a concave endoluminal image strongly suggesting
embolic material (Figures 3(a) and 3(b)) . The other coro-
nary arteries were normal. Intracoronary catheter aspiration
was attempted but was not successful. In addition, percu-
taneous coronary intervention was attempted but was also
unsuccessful due to the distal location of coronary throm-
bus. We decided not to use thrombolytic therapy because
there are fewer published reports and their results are not
deﬁnitive. On Day 8, a transthoracic echocardiography only
showed dyskinesia of the anterior and apical segments of the
left ventricle and persistent image suggesting intraventric-
ular thrombus and severe systolic dysfunction. The patient
received tiroﬁban intravenous therapy 48 hours after the
procedure. Low molecular weight heparin was administrated
following warfarin anticoagulation. The patient was dis-
charged one day later on acetylsalicylic acid, beta-blockers,
and angiotensin-converting enzyme inhibitor therapy.
3. Discussion
Mechanical heart valves are thrombogenic, and anticoagu-
lation is essential to prevent thromboembolism and acute
thrombotic obstruction [2]. Coronary artery embolism is
(a)
(b)
Figure 3: Coronary angiograms showing distal occlusion of the left
anterior descending coronary artery with a concave endoluminal
image strongly suggesting embolic material in two diﬀerent projec-
tions (white arrows), mechanical aortic valve prosthesis (large black
arrow) and mitral valve repair (small black arrow).
not a rare cause of acute transmural myocardial infarction,
representing an important entity in terms of etiology and
clinicaltreatment[4],withincidenceof10to13%inautopsy
series [5]. The consequences of myocardial infarction sec-
ondary to coronary artery embolism depend on both the size
of the embolus and the luminal diameter of the vessel [5, 6].
Coronary embolism should always be suspected espe-
cially in the context of sudden chest pain in patients
with valvular prosthesis, chronic atrial ﬁbrillation, dilated
cardiomyopathy, infective endocarditis, intracardiac shunts,
cardiac myxoma, mural thrombi, and hypercoagulable states
[1, 2, 7, 8]. It has also been observed that most emboli
involve the left coronary system, which could be due to
the preferential ﬂow into the artery related to aortic valve
morphology [9], as described in our case. However, there is
no consensus on the best treatment for coronary embolism.
When a patient presents early with myocardial infarction
and ST segment elevation, thrombolysis or percutaneous
transluminal coronary angioplasty are two options. Local
thrombolysis can be considered but is cumbersome and
often ineﬀective. However, some authors have considered
thecurrentmedicalapproachwithintravenousthrombolytic
therapy [4, 10–12]. Although there is some evidence that a
double regimen with thrombolytic agents is superior to a
single regimen, published reports are few and the results areCase Reports in Medicine 3
not deﬁnitive [7]. If the source of the embolus is infective
vegetation, thrombolysis is contraindicated. There is a risk of
distal embolization causing complete obstruction distally in
as m a l l e rb r a n c h[ 5].
Percutaneous transluminal coronary angioplasty and
stenting may be used, as reported by Hern´ andez et al.
[13] in three interventional cases in which patients with
coronary embolism and consequent acute myocardial infarc-
tion were treated successfully. In this context, Kiernan et
al. [1] reported a 65-year-old male with mechanical aortic
valve prosthesis and acute myocardial infarction due to
coronary artery embolism. This individual decided to stop
taking his warfarin considering previous periods involving
bleeding possibly related to interaction between warfarin-
metabolizing enzymes and taking a “herbal remedy” for pain
causing an inappropriately high INR reading. Diﬀerently, in
our case, the possible etiology of embolic manifestation was
the concomitant presence of multiple thromboembolic risk
factors,including smoking, usingoralcontraceptivepillsand
discontinued taking of warfarin.
Successful catheter aspiration embolectomy has been
described by some authors [1, 7, 14, 15]. To prevent distal
embolization, Belli et al. [14] and Beran et al. [15]d e s c r i b e d
the use of commercial systems to aspirate thrombus from a
native coronaryarteryand to improve the safetyof epicardial
ﬂow. In our patient, catheter aspiration embolectomy for
the intracoronary embolism was not eﬀective. The complete
distal obstruction of the left anterior descending coronary
artery turned this procedure unfeasible. Still, the location of
the coronary thrombus was a challenging place to reach and
treat using percutaneous coronary intervention. In this case,
anticoagulation with heparin and intravenous glycoprotein
inhibitors was performed. This may not result in thrombus
resolution but may prevent further increase in thrombus size
[5]. It is also important to emphasize the need for aggressive
anticoagulation, particularly in patients with mechanical
prostheses, according to ACC/AHA guidelines [16].
The present report described a case of acute myocardial
infarction due to coronary artery embolism in a smoker
patient with mechanical aortic valve prosthesis who decided
to abruptly discontinue her warfarin and started taking oral
contraceptive pills three weeks earlier. It illustrates, once
again, the risks of embolic events in high-risk patients,
alerting for the hypothesis of embolic myocardial infarction
insimilarsituations.Inthiscontext,thepatienteducationon
the optimal anticoagulation with warfarin and the medical
advice about imminent thromboembolic risks are of extreme
importance.
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